0001209191-23-021201.txt : 20230327
0001209191-23-021201.hdr.sgml : 20230327
20230327160502
ACCESSION NUMBER: 0001209191-23-021201
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230323
FILED AS OF DATE: 20230327
DATE AS OF CHANGE: 20230327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kiener Peter A
CENTRAL INDEX KEY: 0001328146
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38327
FILM NUMBER: 23764545
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cue Biopharma, Inc.
CENTRAL INDEX KEY: 0001645460
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473324577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
BUSINESS PHONE: 617-949-2680
MAIL ADDRESS:
STREET 1: 40 GUEST STREET
CITY: BOSTON
STATE: MA
ZIP: 02135
FORMER COMPANY:
FORMER CONFORMED NAME: Imagen Biopharma, Inc.
DATE OF NAME CHANGE: 20150617
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-23
0
0001645460
Cue Biopharma, Inc.
CUE
0001328146
Kiener Peter A
C/O CUE BIOPHARMA INC.
40 GUEST STREET
BOSTON
MA
02135
1
0
0
0
0
Common Stock
2023-03-23
4
M
0
9682
2.86
A
9682
D
Common Stock
2023-03-23
4
S
0
9325
3.28
D
357
D
Stock Option (right to buy)
2.86
2023-03-23
4
M
0
9682
0.00
D
2023-03-23
Common Stock
9682
96062
D
Sale to cover exercise price of cashless exercise of stock option.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 to $3.31, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
This Stock Option became exercisable in five equal annual installments beginning March 23, 2017 and is fully vested. This stock option expired on March 23, 2023.
/s/ Peter Kiener by Colin Sandercock, attorney-in-fact
2023-03-27